RVPH insider transaction filings
REVIVA PHARMACEUTICALS HOLDINGS, INC. — 8 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-03-20. Screen RVPH transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-20 | 4 | Prabhu Narayan — Chief Financial Officer | Grant/award (A): 40,925 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Bhat Laxminarayan — President and CEO, Director | Grant/award (A): 109,150 (derivative) @ $0 · Grant/award (A): 40,925 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Funtleyder Leslie D. — Director | Grant/award (A): 8,200 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Margolin Richard A — Director | Grant/award (A): 8,200 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | Patel Purav — Director | Grant/award (A): 8,200 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | SAXENA PARAG — Director | Grant/award (A): 8,200 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Narayan Prabhu — Chief Financial Officer | Grant/award (A): 194,250 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | Bhat Laxminarayan — President and CEO, Director, 10% owner | Grant/award (A): 519,000 (derivative) @ $0 · Grant/award (A): 181,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — REVIVA PHARMACEUTICALS HOLDINGS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events | EDGAR |
| 2026-04-15 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-19 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events | EDGAR |
| 2025-12-23 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RVPH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →